α-Glucosidase Inhibitors from the Bark Extract of Ethno-Antidiabetic Ceriops tagal (Perr.) C.B. Rob

Bernard S. Canusa, Ivan Lawag, Oliver B. Villaflores, Vitthal D. Wagh, Michal Korinek, Yi-Hong Tsai, Fang-Rong Chang, Alicia M. Aguinaldo

Research output: Contribution to journalArticlepeer-review

20 Downloads (Pure)

Abstract

The bark of Ceriops tagal has been used in the Philippines for folk treatment of diabetes mellitus (DM). Through an α-glucosidase inhibition assay guided isolation, constituents from the detannified methanolic bark extract were isolated and identified to be methyl 2,4-dihydroxy-3,6- dimethyl benzoate (1), isopimar-7-ene-15S,16-diol (2), betulinic acid (3), lupeol (4), and methyl 2,4-dihydroxy-6-methyl benzoate (5). Compounds 3 (IC50 = 5.31 μM) and 4 (IC50 = 55.84 μM)showed a more potent activity against α-glucosidase than the positive control, 1-deoxynojirimycin (IC50 = 79.16 μM). This is the first report on the presence of the weakly active compounds (1, 2, and 5) (IC50 > 75 μM) in the genus Ceriops and the first report on the biological activity of Compound 2. Enzyme kinetic studies suggested that betulinic acid is an uncompetitive type of inhibitor, with lupeol as a non-competitive type. This study provides evidence on the possible mechanism of the antidiabetic property of C. tagal associated with its traditional use. It supports the possible utilization of the bark for development to prevent or treat diabetes
Original languageEnglish
Pages (from-to)25-60
Number of pages36
JournalPhilippine Journal of Science
Volume151
Issue numberS1
Publication statusPublished - 18 Aug 2021

Fingerprint

Dive into the research topics of 'α-Glucosidase Inhibitors from the Bark Extract of Ethno-Antidiabetic Ceriops tagal (Perr.) C.B. Rob'. Together they form a unique fingerprint.

Cite this